D1.1 -New business models for personalized medical products

Italy is considered as one of the oldest countries in the world. Having the life expectancy of 81.77 years, Italy has been ranked as the 7th country in terms of life expectancy (WHO, 2013). Although the length of lives has been increased, but still there is gap between lifespan and health span. While the life expectancy in 2013 was 81.77 years, the healthy life expectancy which is an indicator showing the average number of years a person aged over 60 can expect to live in a good health is 18.5 years showing that an elder person can be in a suitable health situation till 78.5 and not 82 (Global AgeWatch; www.helpage.org). In this regard, not only the healthcare management matters a lot, but also high quality medical devices and products which can increase the quality of life of elder people and patients are quite important. Consequently, personalized medical devices can be seen as a potential driver to increase the quality of life of patients thanks to have a design based on each patient's requirements. In the recent years, the quick development of emerging technologies such as rapid prototyping, 3D printing and micro-manufacturing makes them proper enablers for production of personalized products including medical devices. These technologies can act as enablers not only to facilitate production of personalized medical devices, but also in converting the hospitals to producer of such devices instead of being just a user. This deliverable aims at developing a business model designing and proposing new viable business models for manufacturing personalized medical products in close interaction with industrial and clinical partners. To this end, first the scope of deliverables has been defined through definition problem and then the goal to be achieved (Chapter 1). Thereafter, chapter 2 presents a methodology which clarifies major activities and steps toward the final objective of the task. As a first step, a preliminary stakeholder analysis is done to map the existing stakeholders and analyse the benefits and challenegs of each of them in the scope of Fab@Hospiatl (Chapter 3). Chapter 4 is dedicated to demonstration of the results of a broad literature review which has been performed in terms of business models for personalization, healthcare and manufacturing. As a result, the chapter concludes with selection of the most proper business model framework to be adopted. In chapter 5, the selected business model is modified to be compatible with the scope of Fab@Hospital. Later through combination of different options of building blocks of business model, several alternatives will be configured. Chapter 6 is dedicated to feasibility analysis of the developed alternatives trough both qualitative and quantitative analysis. Finally in chapter 7, the most suitable business model alternative will be introduced based on the results of feasibility analysis.